References:
[1] Gadducci A., Carinelli S., Aletti G. Neuroendrocrine tumors of
the uterine cervix: A therapeutic challenge for gynecologic oncologists.Gynecologic Oncology . 2017;144(3):637‐646.
[2] Rindi G., Klimstra D., Abedi-Ardekani B., et al. A common
classification framework for neuroendocrine neoplasms: an International
Agency for Research on Cancer (IARC) and World Health Organization (WHO)
expert consensus proposal. Modern Pathology.2018;31(12):1770‐1786.
[3] Bhatla N., Berek J., Cuello Fredes M., et al. Revised FIGO
staging for carcinoma of the cervix uteri. International Journal
of Gynecology & Obstetrics. 2019;145(1):129‐135.
[4] Chen J., Macdonald O., Gaffney D. Incidence, mortality, and
prognostic factors of small cell carcinoma of the cervix.Obstetrics & Gynecology. 2008;111(6):1394-1402.
[5] Ramkumar S., Dhingra A., Jyotsna V., et al. Ectopic insulin
secreting neuroendocrine tumor of kidney with recurrent hypoglycemia: a
diagnostic dilemma. BMC Endocrine Disorders. 2014; 14:36.
[6] Seckl M., Mulholland P., Bishop A., et al. Hypoglycemia due to
an insulin-secreting small-cell carcinoma of the cervix. New
England Journal of Medicine . 1999;341(10):733‐736.
[7] Kiang D., Bauer G., Kennedy B. Immunoassayable insulin in
carcinoma of the cervix associated with hypoglycemia. Cancer.1973;31(4):801‐805.
[8] Gilks C., Young R., Gersell D., Clement P. Large cell
neuroendocrine carcinoma of the uterine cervix: A clinicopathologic
study of 12 cases. American Journal of Surgical Pathology.1997;21:905–914.
[9] Mathur A., Gorden P., Libutti S.. Insulinoma. Surgical
Clinics of North America . 2009; 89(5):1105–1121.
[10] Jürgensen C., Schuppan D., Neser F., et al. EUS-guided alcohol
ablation of an insulinoma. Gastrointestinal Endoscopy .
2006;63(7):1059–1062.
[11] Limmer S., Huppert P., Juette V., et al. Radiofrequency
ablation of solitary pancreatic insulinoma in a patient with episodes of
severe hypoglycemia. European Journal of Gastroenterology &
Hepatology. 2009;21(9):1097–1101.